Date | Time | Source | Headline | Symbol | Company |
02/14/2019 | 6:43AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
04/16/2018 | 4:08PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/16/2018 | 8:02AM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/09/2018 | 10:52AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:18PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/07/2018 | 6:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/06/2018 | 8:33AM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/06/2018 | 8:30AM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/06/2018 | 8:28AM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/06/2018 | 8:26AM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/06/2018 | 8:24AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/06/2018 | 8:13AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/06/2018 | 8:02AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/05/2018 | 8:19AM | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/05/2018 | 8:13AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/05/2018 | 8:03AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/05/2018 | 8:02AM | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
03/05/2018 | 8:02AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |